Citicoline PCD Pharma Franchise Company
Cafoli Lifecare offers a Citicoline range of 9 formulations across tablets, syrup and injection, manufactured in WHO-GMP certified facilities. Distributors serving the neurology and psychiatry segment can secure district-wise monopoly franchise rights on this established neuroprotective molecule.
What is Citicoline?
Citicoline (CDP-choline) is a naturally occurring compound that serves as an intermediate in the synthesis of phosphatidylcholine, a key neuronal cell membrane component. It supports membrane repair and neurotransmitter production and is used as a neuroprotective agent. Compound details are available on PubChem.
Therapeutic Applications
Citicoline is used in acute ischemic stroke recovery, traumatic brain injury, age-related memory impairment and cognitive decline, often combined with piracetam. Prescribers include neurologists, neurosurgeons, psychiatrists and consultant physicians, with injectable forms used in hospital settings.
Why Citicoline is a High-Potential Molecule for Distributors
Neurological and neurocognitive disorders are increasing with India's ageing demographic, and citicoline is a mainstay neuroprotective across stroke units and neuro OPDs. Because it spans injectable acute care and oral maintenance, a single franchise can capture both hospital tenders and long-term retail refills, an attractive dual channel within the higher-value neuro segment.
Why Choose Cafoli Lifecare
Cafoli Lifecare is a WHO-GMP compliant, DCGI-approved PCD pharma company with 1000+ franchise partners across India. Partners receive district-wise monopoly rights, promotional inputs including visual aids, MR bags and product cards, and consistent stock availability backed by quality-tested manufacturing.
References
- PubChem: Citicoline
- PubMed: Citicoline in stroke
Our formulations of Citicoline find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: